B2B Companies Can Now Search Verified Local Leads With Targetron's New Directory Platform
05/05/2025, Anchorage, AK // KISS PR Brand Story PressWire //
Targetron, a growing platform that equips sales and marketing teams with accurate business data, has officially rolled out its new B2B Local Leads Directory — a searchable tool designed to make regional B2B prospecting more efficient, precise, and scalable.
This new product gives users access to verified local business data by allowing them to search companies by location, category, or keyword. It's built for professionals who rely on outbound outreach and need accurate, up-to-date contacts to generate leads and grow their pipeline. The tool eliminates the need for hours of manual research or cobbled-together databases by offering on-demand access to business listings organized by city, region, or country.
Each lead includes key details such as business name, address, phone number, category, and website — making it easier to personalize communication and plan outreach campaigns more strategically. Users can also download the leads in a structured, ready-to-use format.
Key Features of the B2B Local Leads Directory:
This launch reflects Targetron's commitment to simplifying the lead generation process, particularly for small teams and agencies that don't have the time or tools to manage complex data pipelines. By offering reliable, localized data in a user-friendly format, the platform supports a wide range of use cases — from regional market expansion and local campaign targeting to client acquisition and B2B service outreach.
The B2B Local Leads Directory is already being adopted by sales teams, consultants, growth marketers, and local service providers who need targeted leads for outreach campaigns across different locations. With an emphasis on transparency, flexibility, and ease of use, the tool removes the friction that often comes with sourcing B2B contacts — especially in niche or regional markets.
The platform is live and accessible globally. To explore the B2B Local Leads Directory or try it out, visit Targetron's website.
About Targetron
Targetron is a business data platform built to make B2B prospecting faster, smarter, and more reliable. The company focuses on helping sales and marketing teams access clean, verified data without the need for scraping, expensive software, or outdated lists. Its tools are used by businesses of all sizes to find and connect with potential clients across cities, industries, and countries.
Contact Info:
Name: Kate Spake
Email: [email protected]
Company the release is about: Targetron, Inc

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
18 minutes ago
- Yahoo
Why CoreWeave, Inc. (CRWV) Skyrocketed Today
We recently published a list of . In this article, we are going to take a look at where CoreWeave, Inc. (NASDAQ:CRWV) stands against other Wednesday's best-performing stocks. CoreWeave rallied for a fourth consecutive day on Wednesday, jumping 8.39 percent to close at $163.10 apiece following the unveiling of record-breaking performance results using Nvidia Corp.'s latest Grace Blackwell chips. In a statement, CoreWeave, Inc. (NASDAQ:CRWV) said that it used 2,496 Nvidia GPUs on its AI-optimized cloud platform, making its submission the largest-ever benchmarked under MLPerf. A close-up of a digital cloud, signifying the expansive reach of the software-as-a-service solution. CoreWeave, Inc. (NASDAQ:CRWV) said that the test was 34x larger than the only other submission from a cloud provider. 'AI labs and enterprises choose CoreWeave because we deliver a purpose-built cloud platform with the scale, performance, and reliability that their workloads demand,' said CoreWeave, Inc. (NASDAQ:CRWV) Chief Technology Officer Peter Salanki. 'These MLPerf results reinforce our leadership in supporting today's most demanding AI workloads,' he added. The unveiling followed the company's new $7-billion deal with Applied Digital Corporation (NASDAQ:APLD), which covered two 15-year lease agreements, under which the latter will deliver 250 megawatts of critical IT load to host its artificial intelligence (AI) and high-performance computing (HPC) infrastructure at its Ellendale, North Dakota data center campus. READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
31 minutes ago
- Yahoo
Why Reddit, Inc. (RDDT) Skyrocketed Today
We recently published a list of . In this article, we are going to take a look at where Reddit, Inc. (NYSE:RDDT) stands against other Wednesday's best-performing stocks. Reddit grew its share prices by 6.68 percent on Wednesday to end at $118.21 apiece following news that it sued an Artificial Intelligence company for scraping its data without its permission. In a copy of the lawsuit posted on its website, Reddit, Inc. (NYSE:RDDT) claimed that AI firm Anthropic was training its Claude chatbot on its data since December 2021. A close up of two hands creating a social media post on Bumble Inc. app. According to Reddit, Inc. (NYSE:RDDT), filing a lawsuit was its final option to force Anthropic to stop its alleged unlawful practices. 'We will not tolerate profit-seeking entities like Anthropic commercially exploiting Reddit content for billions of dollars without any return for redditors or respect for their privacy,' the company said in a statement. 'A.I. companies should not be allowed to scrape information and content from people without clear limitations on how they can use that data.' Anthropic has yet to issue a statement on the allegations. READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires. Disclosure: None. This article is originally published at Insider Monkey.
Yahoo
38 minutes ago
- Yahoo
Why ImmunityBio, Inc. (IBRX) Skyrocketed Today
We recently published a list of . In this article, we are going to take a look at where ImmunityBio, Inc. (NASDAQ:IBRX) stands against other Wednesday's best-performing stocks. ImmunityBio extended its winning streak to a fifth consecutive day on Wednesday, jumping 8.1 percent to finish at $2.93 apiece as investors cheered the Food and Drug Administration's (FDA) green light for the company to expand the access of its Anktiva treatment to patients with solid tumors. According to ImmunityBio, Inc. (NASDAQ:IBRX), it was granted by the FDA to treat lymphopenia in adult patients with refractory or relapsed solid tumors. 'Lymphopenia has long been recognized as a major driver and predictor of early mortality in cancer—yet until now, it has remained unaddressed,' said ImmunityBio, Inc. (NASDAQ:IBRX) founder and Executive Chairman Patrick Soon-Shiong. A technician analyzing natural killer cells, as part of an immune system study and research into therapeutical agents. 'This FDA authorization allows all patients with solid tumors suffering from immune collapse following first-line therapy of chemo, radiation, or immunotherapy to access ANKTIVA. The survival benefit we observed at ASCO 2025 in 3rd to 6th line advanced metastatic pancreatic cancer confirms that restoring lymphocyte levels, rather than depleting them, can change the course of disease.' Following the announcement, the company earned a 'buy' recommendation and a price target of $8 from investment firm HC Wainwright. READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data